Cancer cells often exhibit elevated levels of ROS due to increased metabolic activity, mitochondrial dysfunction, and oncogene activation. Furthermore, the tumor microenvironment, characterized by hypoxia and inflammation, can also contribute to increased ROS production. These factors collectively create a pro-oxidant environment that favors cancer cell survival and growth.
